Editorial Policies

Focus and Scope

Journal of Transdisciplinary Biomedicine is an hybrid open access and peer-reviewed journal that publishes original research articles associated with various interdisciplinary field of Biomedical Sciences such as molecular basis of biological activity between biomolecules including the interactions between DNA, RNA, genes and proteins and their biosynthesis in various disciplines such as imaging, bioengineering, diagnostics, prognostics, therapeutics, biophysics, chemistry, pharmacology, theranostics, bioinformatics, biomedical sciences and clinical sciences. The journal also includes short communication and review articles.

The scope of the journal is to covers in vitro, ex vivo, in vivo biomedical sciences application in various disciplines. This would be the ideal platform for biomedical scientist, molecular biologist, geneticist, bioinformatician, genetic engineer and clinical scientist that involved in transdisciplinary biomedicine research to create new conceptual, theoretical, methodological and translational innovations that integrate and move beyond discipline-specific approaches to address a common problem.

 

Section Policies

Editorial

Editorial reflects the opinion of an Editorial Board member or staff for particular Journal highlighting recent changes, concerned issues or announcements in relevance to the journal. This may include editorial management and policies.

Unchecked Open Submissions Checked Indexed Unchecked Peer Reviewed

Review Article

Reviews article is summarized descriptions of recent findings and significant developments at particular subject area of research considering the Journal’s scope. They should include critical assessments of novel technologies, evaluation of subject advancement, elucidate unresolved questions, comparative analysis with a substantial coverage of previous works and highlight future prospects. Although there are no restrictions with the length and content of a review, authors should consider drawing reader’s attention and interest with quality information.

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Original Research Article

Original research article should contain completely new principal research testifying major contributions to the field. The study should represent new findings or discoveries in a subject area that were not published before. The report may contain significant findings, methodology importance and considerable evidence to the conclusions.

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Mini-review

Mini-review is summarized descriptions based on one or more recent findings and significant developments at particular subject area of research considering the Journal’s scope. It is usually commissioned to create interest on the work and warrant further commentaries on the published articles.

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Perspective Article

Perspective article describes new or potentially unconventional point-of-views on existing clinical observations.

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Commentary

Commentary is short account commissioned by the Editorial board and call for attention on the current issues confined to a particular subject area while sometimes unsolicited articles are accepted from contemporary scientists or experts in the field. The context is to analyze the issues of interest to readers or a discussion on current research and recently published articles in the Journal. Commentaries may also include editorial opinion relevant to scope of the Journal and discuss external implications such as new technology, grant applications, peer reviewing process on research.

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Database Article

Database article should contain vast biomedical information made available to wide utility, accessibility for the retrieval of data.

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Short Communication

Short communications report a brief and concise study. Short communications are not peer reviewed, and as a guideline, must not have more than 30 references.

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Correspondence Article

Correspondence article is letter addressed to the Editor with a short comment on topical issues or reader’s reaction corresponding to an informal publication previously published in the journal. Usually correspondences will not be peer reviewed and should not contain technical comments on research articles or principal research data.

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed
 

Peer Review Process

All manuscripts submitted to the Journal of Transdisciplinary Biomedicine are subjected to a stringent peer review process. This is to uphold the high quality of papers published in this journal and ensure that the reporting of research work is truthful and precise.

  1. All submitted manuscript are firstly handled by our managing editor, who will check the manuscript for plagiarism, in which rejection of the manuscript can take place at this stage by the managing editor if plagiarism occurs in the manuscript.
  2. After the plagiarism check is completed and results are deemed satisfactory, the managing editor will pass the manuscript to the Editor-in-Chief who will undertake the peer review process, or at times pass the task to one of the Associate Editors.
  3. A minimum of 2 reviewers will be selected from the pool of reviewers available according to their expertise and suitability to the subject matter of the manuscript. Reviewers will have to give their comments and recommendations (Accept, Minor Revisions, Major Revisions or Reject) to the Editor-in-Chief or Associate Editor for them to make a final decision on the paper, and their comments will help the authors improve their papers.
  4. Upon recommendations by the reviewers, the Editor-in-Chief or the Associate Editor can make a final decision on the paper and inform the author on their decision, adding comments to the Authors to make improvements in their research or paper.
    • If the decision is to Accept (no amendments required by author) the manuscript, the manuscript will be sent to the Editing stage.
    • If Editor-in-Chief suggests Minor Revisions, authors are given a maximum of 30 days to revise and resubmit the article.
    • If Editor-in-Chief suggests Major Revisions, authors are given a maximum of 90 days to revise and resubmit the article for a second (or third) round of review.
    • If the decision is to Reject the manuscript, the author will be notified and the rejected manuscript will be archived and the peer review process ends.
  5. An accepted paper will be sent for Copy Editing, Layout Editing and Proofreading before publication. Correspondence between the authors and editors will be required here in order to improve the language and/or look of the manuscript. After the Editing stage is completed, authors are required to check the PDF file of the final version before the article is published. EnPress Publisher registers DOI for the manuscript after publication, in which the article is immediately accessible to the public. You may refer to Peer Review Process Flowchart for more details.
  6. Authors may appeal for a rejected submission. Appeal requests must be made in writing to contact@enpress-publisher.com with detailed reasons for the appeal and point by point responses to the reviewers’ remarks. Decisions on appeals are final and no further consideration will be made.

 

Publication Frequency

The publication frequency of Journal of Transdisciplinary Biomedicine is quarterly

 

Hybrid Open Access

 

Green Open Access

Gold Open Access

TypeSubscription-BasedOpen Access
Fully peer reviewedYesYes
APCWaivedPaid to be Open Access
Copyright TransferYesNo
Options
  • Self-archive the author’s draft copy of the article
  • Link the article to the journal site by Doi
  •  Publish as open access article
Accessibility
  • Access upon subscription
  • Embargo period may apply
  •  Free Access
Publication
  • Immediately publish post-print with the watermark “Accepted” to increase early visibility
  • Immediately publish post-print with the watermark “Accepted” to increase early visibility
Creative common licenseCC BY-NC-ND 4.0CC BY-NC 4.0



 

Conflict of Interest

All manuscripts for articles, original research reports, editorials, comments, reviews and letters that are submitted to the journal must be accompanied by a conflict of interest disclosure statement or a declaration by the authors that they do not have any conflict of interest to declare. This include NO affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.

 

Informed Consent

All information which could contribute to identify patients, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, or pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives explicit written informed consent for publication.

 

Human and Animal Rights

Human

When reporting studies that involve human subjects, authors should abide to the Declaration of Helsinki principles of 1975, as revised in 2005. Authors should include a statement that the studies have been approved by the appropriate Research Ethics Committee or Institutional Review Board. Existence of doubtful aspects of study required the authors to explain the rationale for their approach and demonstrate that the independent ethics committee or institutional review board explicitly approved the doubtful study.

 

Animal

When reporting experiments on animals, authors must adhere to high ethical standards concerning animals welfare. Authors should include a statement to indicate whether the international, national, and/or institutional guidelines for the human animal treatment and complies with relevant legislation. Clinical trials and experiments should abide to the guidelines provided by the National Institute of Health (NIH) in the USA regarding the care and use of animals for experimental procedures or with the European Communities Council Directive of 24 November 1986 (86/609/EEC) and in accordance with local laws and regulations. Clinical studies should include the name of the trial registry and trial registration number in the statement. For experiments involving client-owned animals required statement of informed client consent and adhere to best practise of veterinary care. 

 

Reporting Guidelines for Specific Study Designs

For the specific study design, such as randomized control studies, pre-clinical animal studies, studies of diagnostic, meta-analyses, observational studies and non-randomized studies, it is recommended that the authors follow the reporting guidelines listed in the following table.

 

Type of Study

 

Reporting Guidelines

Source

Randomized Trials

CONSORT

http://www.consort-statement.org/

Animal Studies

ARRIVE

http://www.nc3rs.org.uk/arrive-guidelines

Observational Studies

STROBE

http://www.strobe-statement.org/

Diagnostic/Prognostic Studies

STARD

http://www.stard-statement.org/

Systematic reviews and meta-analyses

PRISMA

http://www.prisma-statement.org/


 

Code of Ethics

EnPress Publisher and editors adhere to the Code of Conduct for Journal Editors and Code of Conduct for Publishers as stated by Committee on Publication Ethics (COPE).

Enpress Publisher ensures the legitimacy of this journal by practising to be transparent to the authors and researchers in accordance to the Principles of Transparency and Best Practice in Scholarly Publishing.

Complaints may submitted to Editorial office and the journal editorial team will address the complaint according to the Publishing protocol.

 

Authorship

Authorship should be limited to people who have contributed substantially to the work. Authors must indicate their specific contributions to the published work. This information should be listed in the manuscript under the section ‘Author Contribution’. Examples of contributions include: designed research, performed research, contributed new reagents or analytic tools, analyzed data, wrote the paper.

For more information on submission’s format, please refer to the ‘Author Guidelines’ link accessible from the ‘About’ button at the top row of this page.

The corresponding author should be clearly indicated for all manuscripts submitted. A maximum of two corresponding authors are allowed for the responsibilities associated. The corresponding author(s) is responsible for:

  • Obtaining permission from all the authors mentioned in the manuscript
  • Ensuring adherence to all editorial and submission policies and for any communications and actions that may be necessary after publication
  • Including written permission from the authors of the work concerned for any mention of any unpublished material included in the manuscript, e.g. data from manuscripts-in-press, personal communication, or work in preparation.

 

Plagiarism

The editorial team does not permit of any plagiarism attempts in the manuscript. Each manuscripts submitted will undergo primary screening of originality through iThenticate. If plagiarism is detected, editor will run through the severity of plagiarism and the manuscript will be rejected if the rate of plagiarism is high depending on editorial decision. Therefore, if a manuscript uses a text copied directly from another source, this text must be written in quotation marks and the original source must be cited.

 

Permission and Reprints

Any part of materials published in Journal of Transdisciplinary Biomedicine may not be reproduced without written permission of the publisher. Please click HERE to write in the permission request.

 

Advertising Policies

  1. All advertisements, exhibition or sales are subject to approval of the Publisher which reserves the right to reject or cancel any advertisement at any time.
  2. Advertisers and sponsors have no rights or knowledge on editorial content, decisions or judgment. Editors have no rights and knowledge on advertisement, exhibition or sales. Both advertisement and editorial have been conducted by separate department.
  3. Advertisements or sponsored content will be easily distinguished with the editorial content on the website.
  4. Advertisement products must comply with the relevant laws and regulations in the country/geographic area where the advertisement appears. Advertisements for pharmaceutical products (including new product applications) that are subject to US Food and Drug Administration (FDA) oversight must comply with FDA regulations regarding advertising and promotion.
  5. Publisher will provide google analytics to the advertiser after the ads discontinue.

Further inquiries and purchasing ad space, please contact us.

 

Editorial Policies

A manuscript would not be accepted if it has been published or is currently under consideration for publication in any other journals. The author will need to notify the editorial team if the data in their submission has been presented in conferences.

After acceptance, the Publisher will have the right to edit the work for the original edition and for any revision.